Sarcoma & GIST
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
Clinical Insights
COVID-19 prompts ‘democratization’ of cancer trials
Dr. Alan Lyss reviews a panel discussion about how COVID-19 has affected cancer research.
From the Journals
Hair dye and cancer study ‘offers some reassurance’
Conference Coverage
VTE, sepsis risk increased among COVID-19 patients with cancer
Cancer patients had significantly lower hemoglobin levels, platelet counts, and red and white blood cell counts.
Guidelines
First guideline on NGS testing in cancer, from ESMO
From the Journals
Aspirin may accelerate cancer progression in older adults
From the Journals
COVID-19 impact: Less chemo, immune checkpoint inhibitors, and steroids
A survey finds the COVID-19 pandemic to have a significant impact on oncologists’ decision-making.
From the Journals
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
Feature
ASCO says ‘no’ to home infusions of cancer treatment, with exceptions
The American Society of Clinical Oncology has warned against intravenous infusion of chemotherapy and monoclonal antibodies in cancer patients’...
From the Journals
OK to treat many cancer patients despite pandemic, says ESMO
ESMO recommends against stopping or delaying cancer treatment that can impact survival.
Conference Coverage
CCC19, other registries help define COVID/cancer landscape
New data from CCC19 show an increased risk of death from COVID-19 among non-Hispanic black cancer patients and patients with hematologic...